Caltex Australia (ASX: CTX) advises its realised lagged1 Caltex Refiner Margin (CRM2 ) in respect of CRM sales from production for the month of January and February 2018.
The January unlagged CRM was US$8.77/bbl. This is below the prior month (December 2017: US$11.52/bbl) and below the prior year monthly comparative (US$12.08/bbl). The February unlagged CRM was US$9.95/bbl.
The January unlagged Caltex Singapore Weighted Average Margin was US$10.95/bbl, which is below the prior month (December 2017: US$11.43/bbl) and prior year (January 2017: US$12.82/bbl). The February unlagged Caltex Singapore Weighted Average Margin was US$12.36/bbl, which is above January (US$10.95/bbl) but below the prior year comparative (February 2017: US$13.40/bbl).
Higher Brent crude oil prices drove an unfavourable US($0.16)/bbl pricing lag in January (December 2017: unfavourable US($0.11/bbl) pricing lag) in January. This reversed in February, with lower Brent crude oil prices driving a favourable US$0.15/bbl pricing lag (January 2018: unfavourable US($0.16/bbl) pricing lag).
The January realised CRM was US$8.61/bbl. This is below the December 2017 CRM of US$11.42/bbl and the prior year comparative (January 2017: US$12.43/bbl). The February realised CRM was US$10.10/bbl, above January but below the prior year comparative (February 2017: US$12.71/bbl).
Sales from production in January of 557 ML are above the prior month (December 2017: 512 ML) and prior year comparative (January 2017: 501 ML). Sales from production in February of 475 ML was below January 2018 but above the prior year comparative (February 2017: 425 ML).
For the two months from 1 January 2018 to 28 February 2018, the average realised CRM was US$9.30/bbl (2017: US$12.56/bbl) with CRM sales from production totalling 1,032 ML (2017: 926 ML).
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.